May 4, 2022
Video

A Randomized ADAPT-TAVR Trial: Edoxaban Versus Dual Antiplatelet Therapy for Valve Thrombosis and Cerebral Thromboembolism After Transcatheter Aortic-Valve Replacement

14:21

C. Michael Gibson and Duk-Woo Park discuss the ADAPT-TAVR Trial presented at ACC 2022.

Partner Content

Explore All